La Financiere de L'Echiquier’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$39.5M Sell
427,971
-9,971
-2% -$883K 1.72% 20
2024
Q1
$41.8M Sell
437,942
-9,031
-2% -$759K 1.8% 16
2023
Q4
$34.1M Buy
446,973
+26,891
+6% +$1.87M 1.57% 21
2023
Q3
$29.1M Buy
+420,082
New +$33.8M 1.51% 22
2023
Q2
Sell
-230,874
Closed -$19.1M 101
2023
Q1
$19.1M Buy
+230,874
New +$18.1M 1% 29
2021
Q1
Sell
-7,526
Closed -$687K 76
2020
Q4
$687K Buy
7,526
+1,097
+17% +$91K 0.03% 72
2020
Q3
$514K Buy
6,429
+3,410
+113% +$266K 0.04% 71
2020
Q2
$209K Sell
3,019
-2,939
-49% -$209K 0.02% 67
2020
Q1
$375K Buy
5,958
+2,682
+82% +$193K 0.05% 52
2019
Q4
$255K Buy
+3,276
New +$256K 0.03% 56

Other funds holding EW

La Financiere de L'Echiquier's EW Position: Q2 2024 in Review

La Financiere de L'Echiquier reduced its Edwards Lifesciences (EW) stake by 2.3% in Q2 2024, selling an estimated $883K and leaving 427,971 shares worth $39.5M. The position accounts for 1.72% of the portfolio, ranked #20.

La Financiere de L'Echiquier first reported a position in EW in Q4 2019 and has held it in 10 quarters since. The position peaked at $41.8M in Q1 2024. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • La Financiere de L'Echiquier held 427,971 shares of Edwards Lifesciences worth $39.5M as of Q2 2024.
  • La Financiere de L'Echiquier sold 9,971 Edwards Lifesciences shares in Q2 2024, an estimated $883K.
  • Edwards Lifesciences made up 1.72% of La Financiere de L'Echiquier's portfolio in Q2 2024, its #20 holding.
  • La Financiere de L'Echiquier first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 10 quarters since.
  • La Financiere de L'Echiquier's Edwards Lifesciences position peaked at $41.8M in Q1 2024.
  • 1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on La Financiere de L'Echiquier's 13F filing for Q2 2024, filed 18 Jul 2024.